Diabetic Nephropathy
📧 Sign up to get email alerts when something new happens for Diabetic Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-08-30Clinical Trial Update: Comparison of Soy-milk and Cow Milk Consumption on Inflammatory Factors, Cardiovascular Factors ,Renal Factors, Fibrinolytic Indice and Oxidative Stress Among Type-2 Diabetic Patients With Nephropathy Stage 1 and 2 [Phase 3]
A Phase 3 completed trial comparing soy milk versus cow milk on inflammatory, cardiovascular, renal factors, fibrinolytic indices, and oxida…
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus [Phase 4]
Phase 4 clinical trial evaluating whether combining enalapril and losartan affects proteinuria and inflammatory biomarkers in macroalbuminur…
-
FDA approval · 2011-07-22FDA Approved: CAPTOPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for CAPTOPRIL from Hikma Pharmaceuticals USA Inc., indicating additional approval for this generic A…
-
FDA approval · 2011-06-10FDA Approved: COZAAR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Cozaar (losartan potassium) filed by Organon LLC.
-
FDA approval · 2011-06-06FDA Approved: LOSARTAN POTASSIUM — Original Application (Solco Healthcare US, LLC)
The FDA approved Losartan Potassium as a generic product from Solco Healthcare US, LLC under original ANDA 091497.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial [Phase 3]
Phase 3 ORIENT trial studied olmesartan for reducing incidence of end-stage renal disease in adults with diabetic nephropathy; the study com…
-
FDA approval · 2011-03-30FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for Losartan Potassium from Alembic Pharmaceuticals Limited, confirming approval of a generic produc…
-
FDA approval · 2011-03-22FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for Losartan Potassium submitted by Quallent Pharmaceuticals Health LLC.
-
CLINICAL_TRIALS trial_result · 2011-03-16Clinical Trial Update: Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients [Phase 4]
Phase 4 clinical trial update evaluating sulodexide for reducing albuminuria in Chinese patients with type 2 diabetes and diabetic nephropat…
-
CLINICAL_TRIALS trial_result · 2011-03-09Clinical Trial Update: Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 study evaluating the effects of the amlodipine/benazepril combination on albuminuria in hypertensive patients with type 2 diabetes. …
-
CLINICAL_TRIALS research · 2011-02-04Clinical Trial Update: Study to Assess the Optimal Renoprotective Dose of Aliskiren in Hypertensive Patients With Type 2 Diabetes and Incipient or Overt Nephropathy [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study to identify the optimal renoprotective dose of aliskiren in hypertensive patients wit…
-
FDA approval · 2011-01-12FDA Approved: RAMIPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for RAMIPRIL (ramipril) from Hikma Pharmaceuticals USA Inc., allowing a generic ramipril product to …
-
CLINICAL_TRIALS research · 2011-01-10Clinical Trial Update: An Investigation on the Effect of Candesartan on Early Diabetic Nephropathy
An ongoing clinical trial is investigating the effect of candesartan on early diabetic nephropathy. The status of the study is not specified…
-
CLINICAL_TRIALS trial_result · 2011-01-05Clinical Trial Update: Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy [Phase 4]
A Phase 4 clinical trial evaluating the effect of a thiazolidinedione (TZD) on diabetic retinopathy and nephropathy in people with diabetes;…
-
CLINICAL_TRIALS trial_result · 2010-12-30Clinical Trial Update: Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease [Phase 2]
Phase 2 clinical trial evaluating proteinuria and renal function in diabetic patients with progressive renal disease; results have been post…
-
CLINICAL_TRIALS research · 2010-10-28Clinical Trial Update: Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria [Phase 3]
A Phase 3 clinical trial comparing the antiproteinuric effects of imidapril versus ramipril in adults with type 2 diabetes and hypertension …
-
FDA approval · 2010-10-22FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for Losartan Potassium submitted by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2010-10-06FDA Approved: LOSARTAN POTASSIUM — Original Application (AiPing Pharmaceutical, Inc.)
FDA approved AiPing Pharmaceutical, Inc.'s Losartan Potassium as an original application generic, authorizing the same uses as the reference…
-
FDA approval · 2010-10-06FDA Approved: LOSARTAN POTASSIUM — Original Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' original ANDA for Losartan Potassium, a generic version of the hypertension medicine.
-
FDA approval · 2010-10-06FDA Approved: LOSARTAN POTASSIUM — Original Application (Quallent Pharmaceuticals Health LLC)
The FDA approved Quallent Pharmaceuticals Health LLC's generic Losartan Potassium under an original ANDA (ANDA078243).
-
FDA approval · 2010-10-06FDA Approved: LOSARTAN POTASSIUM 25 MG — Original Application (Strides Pharma Science Limited)
FDA approved Losartan Potassium 25 mg as an original ANDA by Strides Pharma Science Limited, making a generic version of losartan potassium …
-
FDA approval · 2010-10-06FDA Approved: LOSARTAN POTASSIUM — Original Application (Alembic Pharmaceuticals Limited)
FDA approved an original ANDA for Losartan Potassium from Alembic Pharmaceuticals Limited, enabling a generic version for hypertension and r…
-
CLINICAL_TRIALS trial_result · 2010-09-29Clinical Trial Update: Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy [Phase 2]
A Phase 2 study of olmesartan medoxomil (CS-866) in patients with chronic glomerulonephritis or diabetic nephropathy has completed.
-
FDA approval · 2010-09-23FDA Approved: COZAAR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Cozaar (losartan potassium) from Organon LLC.
-
CLINICAL_TRIALS trial_result · 2010-09-14Clinical Trial Update: The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors [Phase 2]
Phase 2 trial evaluating paricalcitol capsules for reducing albuminuria in patients with type 2 diabetic nephropathy on renin-angiotensin sy…